ENTITY

Sumitomo Pharma (4506 JP)

73

Analysis

Health Care • Japan

Sumitomo Dainippon Pharma Co., Ltd. mainly manufactures and markets pharmaceuticals for human and veterinary use. The Company also produces and sells livestock feeds, food additives, and chemical products, as well as conducts clinical pathology tests for animals. Sumitomo Dainippon Pharma conducts businesses across worldwide.

more

Refresh

Exchange Announcement • 30 Oct 2024 12:30

Notice Concerning Finance Costs

Exchange Announcement • 30 Oct 2024 12:30

Summary Of Consolidated Financial Results For The Second Quarter (First Half) Of The Year Ending March 31, 2025 [Ifrs]

Exchange Announcement • 30 Oct 2024 12:30

Conference On Q2 Fy2024 (April 1, 2024 To September 30, 2024) Financial Results

Exchange Announcement • 30 Oct 2024 12:30

Supplementary Financial Data (Ifrs) For The Second Quarter Of The Year Ending March 31, 2025

Exchange Announcement • 30 Oct 2024 12:30

Sumitomo Pharma Announces The Results Of Its Early Retirement Program Offer To Employees In Japan For Business Structural Reform

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x